STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
comments(0)
5-min edit window · permanent after that